Cargando…
CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
Aberrant chromobox (CBX) family protein expression has been reported in a variety of human malignancies. However, the role of CBX6 in hepatocellular carcinoma (HCC) progression and patient prognosis remains unknown. In this study, we found that CBX6 was frequently up-regulated in HCC clinical sample...
Autores principales: | Zheng, Hao, Jiang, Wei-hua, Tian, Tao, Tan, Hai-song, Chen, Ying, Qiao, Guang-lei, Han, Jun, Huang, Sheng-yu, Yang, Yuan, Li, Shuai, Wang, Zhen-guang, Gao, Rong, Ren, Hao, Xing, Hao, Ni, Jun-sheng, Wang, Lin-Hui, Ma, Li-jun, Zhou, Wei-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386654/ https://www.ncbi.nlm.nih.gov/pubmed/28122351 http://dx.doi.org/10.18632/oncotarget.14770 |
Ejemplares similares
-
CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular Carcinoma()
por: Yang, Yu-Feng, et al.
Publicado: (2018) -
Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017) -
Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017) -
Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma
por: Chen, Jiewei, et al.
Publicado: (2018) -
Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1
por: Dang, Xiao-Wei, et al.
Publicado: (2021)